March 13th, 2007
A protein known as CDX2 is inappropriately expressed in the leukemic cell of patients with acute myeloid leukemia (AML), according to a study from Harvard Medical School appearing in the April print issue of the Journal of Clinical Investigation.
…gene encoding CDX2 is expressed in 90% of the patients with AML that they analyzed. Moreover, reducing […]
By Gloria Gamat -- 0 comments
September 23rd, 2006
Cytogen Corporation (Nasdaq: CYTO) has recently published a new data related to its QUADRAMET® (samarium Sm-153 lexidronam injection) product, in an article by Vilmarie Rodriguez, M.D. (a Pediatric Oncologist at The Mayo Clinic in Rochester, Minnesota) entitled “Marrow irradiation with high-dose 153 Samarium-EDTMP followed by chemotherapy and hematopoietic stem cell infusion for acute myelogenous leukemia” […]
By Gloria Gamat -- 0 comments
Recent Comments